Casi pharmaceuticals to participate in the 2024 h.c. wainwright global investment conference

Beijing , sept. 4, 2024 /prnewswire/ -- casi pharmaceuticals, inc. (nasdaq: casi) ("casi" or the "company"), a cayman incorporated biopharmaceutical company specializing in the development and commercialization of innovative therapeutics and pharmaceutical products, today announced its participation in the h.c.

CASI Ratings Summary

CASI Quant Ranking